British American Tobacco (BAT) is a major multinational consumer goods company, founded in 1902, with a strategic focus on transitioning from traditional cigarettes to smokeless tobacco alternatives. BAT’s declared purpose is to create “A Better Tomorrow™” by encouraging smokers to switch to less harmful products and aiming to become predominantly smokeless by 2035. The company operates globally and is heavily involved in lobbying activities within the European Union, registered in the EU Transparency Register since January 21, 2009.
BAT’s lobbying efforts focus on promoting its own interests and those of its members, particularly in the tobacco sector. The company is active in shaping EU policies related to tobacco regulation, harm reduction, and market access for new nicotine products. BAT has faced scrutiny and allegations, including investigations related to corruption and bribery in Africa, which the company denies. It has also actively lobbied against stringent tobacco control policies, such as the “Smokefree Aotearoa” plan in New Zealand and similar policies proposed in the UK, using legal and advocacy strategies to influence policy outcomes.
The company is a member of numerous industry associations and networks that amplify its lobbying reach, including Tobacco Europe, AmCham EU, BusinessEurope, and others. While not a member, BAT supports the Consumer Choice Center, an organization known for opposing tobacco regulation in the EU. BAT’s lobbying expenditures are substantial, with reported spending of between €3.5 million and €4 million in the 2024 financial year alone, reflecting its significant investment in influencing EU policy.
BAT’s lobbying activities include direct engagement with EU institutions, participation in expert groups, and interaction with policymakers to shape tobacco-related legislation and regulation. The company’s approach combines promoting harm reduction products while resisting policies that could negatively impact its business interests.
